JOSEPH JANKOVIC to Vesicular Monoamine Transport Proteins
This is a "connection" page, showing publications JOSEPH JANKOVIC has written about Vesicular Monoamine Transport Proteins.
Connection Strength
2.365
-
Real-World Experience With VMAT2 Inhibitors. Clin Neuropharmacol. 2019 Mar/Apr; 42(2):37-41.
Score: 0.628
-
Deutetrabenazine for the treatment of Huntington's chorea. Expert Rev Neurother. 2018 08; 18(8):625-631.
Score: 0.601
-
Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors. Drugs. 2018 04; 78(5):525-541.
Score: 0.589
-
Real-world experience with VMAT2 inhibitors in Tourette syndrome. J Neurol. 2023 Sep; 270(9):4518-4522.
Score: 0.211
-
Treatment of Tardive Dyskinesia. Neurol Clin. 2020 05; 38(2):379-396.
Score: 0.168
-
Treatment options for chorea. Expert Rev Neurother. 2018 Jan; 18(1):51-63.
Score: 0.143
-
Anti-parkinsonian effects of Nurr1 activator in ubiquitin-proteasome system impairment induced animal model of Parkinson's disease. CNS Neurol Disord Drug Targets. 2012 Sep; 11(6):768-73.
Score: 0.025